• Important Safety Information
  • For Healthcare Professionals
  • Important Safety Information
  • For Healthcare Professionals
  • home
  • More Hide
    • Important Safety Information
    • Prescribing Information
    • For Healthcare Professionals
    • REGISTER
    • Facebook Icon
    • UNDERSTANDING
      NF1 PN
      • About NF1 PN
      • Treatment for NF1 PN
      • Living with NF1 PN
      About NF1 PN Treatment for NF1 PN Living with NF1 PN
    • ABOUT
      KOSELUGO
      • What Is Koselugo?
      • Tumor Response
      What Is Koselugo? Tumor Response
    • SAFETY AND
      SIDE EFFECTS
      • Possible Side Effects
      • Before Starting Treatment
      Possible Side Effects Before Starting Treatment
    • TAKING
      KOSELUGO
      • Taking Koselugo
      • Tips for Taking
      • Taking It on Time
      • Track Their Treatment
      Taking Koselugo Tips for Taking Taking It on Time Track Their Treatment
    • FAQs
    • FAMILY
      RESOURCES
      • Resources
      • Videos
      • Advocacy Organizations
      Resources Videos Advocacy Organizations
    • SAVINGS AND
      SUPPORT
      • OneSource™
      • Register
      OneSource™ Register
    • GLOSSARY
    • Prescribing Information
    • REGISTER
    • Facebook Icon
    • Important Safety Information
    • Prescribing Information
    • For Healthcare Professionals
    • REGISTER
    • Facebook Icon
    • UNDERSTANDING
      NF1 PN
      • About NF1 PN
      • Treatment for NF1 PN
      • Living with NF1 PN
      About NF1 PN Treatment for NF1 PN Living with NF1 PN
    • ABOUT
      KOSELUGO
      • What Is Koselugo?
      • Tumor Response
      What Is Koselugo? Tumor Response
    • SAFETY AND
      SIDE EFFECTS
      • Possible Side Effects
      • Before Starting Treatment
      Possible Side Effects Before Starting Treatment
    • TAKING
      KOSELUGO
      • Taking Koselugo
      • Tips for Taking
      • Taking It on Time
      • Track Their Treatment
      Taking Koselugo Tips for Taking Taking It on Time Track Their Treatment
    • FAQs
    • FAMILY
      RESOURCES
      • Resources
      • Videos
      • Advocacy Organizations
      Resources Videos Advocacy Organizations
    • SAVINGS AND
      SUPPORT
      • OneSource™
      • Register
      OneSource™ Register
    • GLOSSARY
    • Prescribing Information
    • REGISTER
    • Facebook Icon

    Site map

    • Home
    • Understanding NF1 PN
      • About NF1 PN
      • Treatment for NF1 PN
      • Living with NF1 PN
    • About Koselugo
      • What Is Koselugo?
      • Tumor Response
    • Safety and Side Effects
      • Possible Side Effects
      • Before Starting Treatment
    • Taking Koselugo
      • Taking Koselugo
      • Tips for Taking
      • Taking It on Time
      • Track Their Treatment
    • FAQs
    • Family Resources
      • Resources
      • Videos
      • Advocacy Organizations
    • Savings and Support
      • OneSource™
      • Register
    • Glossary

    You are now about to leave the Koselugo website

    This link will take you to a site maintained by a third party who is solely responsible for its content.

    Alexion provides this link as a service to website visitors. Alexion is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.

    Back Continue

    Cancel Ok
    Read More Read Less

    IMPORTANT SAFETY INFORMATION

    Before taking Koselugo, tell your healthcare provider about all of your medical conditions, including if you:

    • have heart problems
    • have eye problems
    • are pregnant or plan to become pregnant. Koselugo can harm your unborn baby
      • Females who could become pregnant and males with female partners who could become pregnant should use effective birth control (contraception) during treatment with Koselugo and for 1 week after your last dose
      • Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with Koselugo
    • are breastfeeding or plan to breastfeed. It is not known if Koselugo passes into your breast milk
      • Do not breastfeed during treatment with Koselugo and for 1 week after your last dose
      • Talk to your healthcare provider about the best way to feed your baby during this time

    Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, or herbal supplements. Especially tell your healthcare provider if you are taking aspirin, blood thinners, or other medicines to treat blood clots. Koselugo contains vitamin E, which may increase your risk of bleeding.

    Koselugo may cause serious side effects, including:

    Heart problems. Koselugo can lower the amount of blood pumped by your heart, which is common and can also be severe. Your healthcare provider will do tests before and during treatment with Koselugo to check how well your heart is working. Tell your healthcare provider right away if you get any of the following signs or symptoms:

    • persistent coughing or wheezing
    • shortness of breath
    • swelling of your ankles and feet
    • tiredness
    • increased heart rate

    Eye problems. Koselugo can cause eye problems that can lead to blindness. Your healthcare provider will check your vision before and during treatment with Koselugo. Tell your healthcare provider right away if you get any of the following signs or symptoms:

    • blurred vision
    • loss of vision
    • dark spots in your vision (floaters)
    • other changes to your vision

    Severe diarrhea. Diarrhea is common with Koselugo and can also be severe. Tell your healthcare provider right away the first time that you get diarrhea during treatment with Koselugo. Your healthcare provider may give you medicine to help control your diarrhea and may tell you to drink more fluids.

    Skin rash. Skin rashes are common with Koselugo and can also be severe. Tell your healthcare provider if you get any of the following signs or symptoms:

    • rash that covers a large area of your body
    • peeling skin
    • blisters

    Muscle problems (rhabdomyolysis). Muscle problems are common with Koselugo and can also be severe. Treatment with Koselugo may increase the level of a muscle enzyme in your blood, which may be a sign of muscle damage. Your healthcare provider should do a blood test to check your muscle enzyme levels before you start taking Koselugo and during treatment. Tell your healthcare provider right away if you get any of the following signs or symptoms:

    • muscle aches or pain
    • muscle spasms and weakness
    • dark, reddish urine

    Your healthcare provider may change your dose, temporarily stop, or permanently ask you to stop taking Koselugo if you have any of these side effects.

    The most common side effects of Koselugo are:

    • vomiting
    • stomach pain
    • nausea
    • dry skin
    • feeling of tiredness, weakness, or lacking energy
    • muscle and bone pain
    • fever
    • inflammation of the mouth
    • headache
    • redness around the fingernails
    • itching

    These are not all the possible side effects of Koselugo.

    INDICATION

    What is Koselugo?

    Koselugo is a prescription medicine that is used to treat children 2 years of age and older with neurofibromatosis type 1 (NF1) who have plexiform neurofibromas that cannot be completely removed by surgery.

    It is not known if Koselugo is safe and effective in children under 2 years of age.

    You may report side effects related to AstraZeneca products by clicking here.

    IMPORTANT SAFETY INFORMATION

    Before taking Koselugo, tell your healthcare provider about all of your medical conditions, including if you:

    • have heart problems
    • have eye problems
    • are pregnant or plan to become pregnant. Koselugo can harm your unborn baby
      • Females who could become pregnant and males with female partners who could become pregnant should use effective birth control (contraception) during treatment with Koselugo and for 1 week after your last dose
      • Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with Koselugo
    • are breastfeeding or plan to breastfeed. It is not known if Koselugo passes into your breast milk
      • Do not breastfeed during treatment with Koselugo and for 1 week after your last dose
      • Talk to your healthcare provider about the best way to feed your baby during this time

    Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, or herbal supplements. Especially tell your healthcare provider if you are taking aspirin, blood thinners, or other medicines to treat blood clots. Koselugo contains vitamin E, which may increase your risk of bleeding.

    Koselugo may cause serious side effects, including:

    Heart problems. Koselugo can lower the amount of blood pumped by your heart, which is common and can also be severe. Your healthcare provider will do tests before and during treatment with Koselugo to check how well your heart is working. Tell your healthcare provider right away if you get any of the following signs or symptoms:

    • persistent coughing or wheezing
    • shortness of breath
    • swelling of your ankles and feet
    • tiredness
    • increased heart rate

    Eye problems. Koselugo can cause eye problems that can lead to blindness. Your healthcare provider will check your vision before and during treatment with Koselugo. Tell your healthcare provider right away if you get any of the following signs or symptoms:

    • blurred vision
    • loss of vision
    • dark spots in your vision (floaters)
    • other changes to your vision

    Severe diarrhea. Diarrhea is common with Koselugo and can also be severe. Tell your healthcare provider right away the first time that you get diarrhea during treatment with Koselugo. Your healthcare provider may give you medicine to help control your diarrhea and may tell you to drink more fluids.

    Skin rash. Skin rashes are common with Koselugo and can also be severe. Tell your healthcare provider if you get any of the following signs or symptoms:

    • rash that covers a large area of your body
    • peeling skin
    • blisters

    Muscle problems (rhabdomyolysis). Muscle problems are common with Koselugo and can also be severe. Treatment with Koselugo may increase the level of a muscle enzyme in your blood, which may be a sign of muscle damage. Your healthcare provider should do a blood test to check your muscle enzyme levels before you start taking Koselugo and during treatment. Tell your healthcare provider right away if you get any of the following signs or symptoms:

    • muscle aches or pain
    • muscle spasms and weakness
    • dark, reddish urine

    Your healthcare provider may change your dose, temporarily stop, or permanently ask you to stop taking Koselugo if you have any of these side effects.

    The most common side effects of Koselugo are:

    • vomiting
    • stomach pain
    • nausea
    • dry skin
    • feeling of tiredness, weakness, or lacking energy
    • muscle and bone pain
    • fever
    • inflammation of the mouth
    • headache
    • redness around the fingernails
    • itching

    These are not all the possible side effects of Koselugo.

    INDICATION

    What is Koselugo?

    Koselugo is a prescription medicine that is used to treat children 2 years of age and older with neurofibromatosis type 1 (NF1) who have plexiform neurofibromas that cannot be completely removed by surgery.

    It is not known if Koselugo is safe and effective in children under 2 years of age.

    You may report side effects related to AstraZeneca products by clicking here.

    Read More Read Less

    Visit Us:

    This site is intended for US Consumers.


    • Contact Us
    • Alexion US Corporate Site
    • Privacy Notice
    • Cookie Notice
    • Legal Statement
    • Site Map
    • Glossary

    KOSELUGO is a registered trademark of the AstraZeneca group of companies.
    ALEXION, the Alexion logo, and the OneSource logo are registered trademarks of Alexion Pharmaceuticals, Inc., and OneSource™ is a trademark of Alexion Pharmaceuticals, Inc.
    © 2022, Alexion Pharmaceuticals, Inc. All rights reserved. US/KOS-NF1/0392 5/22

    Back to top

    Koselugo-Registeration

    Thank you for providing us with this information.